Deltex Medical

Stand number: 45

Deltex Medical - Improving outcomes, saving money by implementing ODM

Deltex Medical is the global leader in Oesophageal Doppler Monitoring (ODM), an innovative new medical technology proven to improve outcomes and save money.

Seminar: 18th June 13:00-13:45 Inside Healthcare, Location SG33

Title: Enhanced Recovery Surgical Programmes: why & how to implement

An expert panel of doctors and managers will discuss short case studies presented by front line doctors who have successfully implemented enhanced recovery programmes in NHS hospitals;

Professor Monty Mythen – UCLH London; Joint National Clinical Lead for Enhanced Recovery Partnership Programme. 

Dr Martin Kuper -  Whittington Hospital London; National Clinical Advisor on Enhanced Recovery for NHS Improvement.

Mr Mike Parker - Darent Valley; President of the Association of Laparoscopic Surgeons.

Colin Callow - National Technology Adoption Centre; Project Manager of Peri-operative Fluid Management Project.

Showcase Content: 

A series of case studies showing how individual NHS hospitals have successfully implemented ODM in major surgery to improve quality of care, improve patient outcome, reduce critical care usage and length of hospital stay, and therefore reduce costs.

ODM is the only technology which directly measures changes in central vascular blood flow, allowing clinicians to optimize each patient’s circulating blood volume during surgery and avoid the problems caused by reduced oxygen delivery. ODM patients recover more quickly and are able to return home sooner.

In his 2007 report, A Framework for Action, Lord Darzi said of ODM “…seven randomized trials have shown simple use of cheap ultrasound technology to reduce length of stay consistently by two to three days in elective intra-abdominal surgery. The evidence-base is clear here and changes should be rapidly implemented across London”. 

ODM has been endorsed by peer reviewed meta-analyses, a US government health technology assessment and in February this year a UK Health Technology Assessment. 

In April 2008 the Centre for Evidence-based Purchasing (CEP) published positive results from its clinical and economic analysis of ODM, and ODM was selected in the first wave of projects for the new NHS National Technology Adoption Centre (NTAC). NTAC’s mission is to work with the NHS “to identify and overcome the barriers to adoption for innovative technologies which have already demonstrated clear benefits to patients and will improve system efficiency”. 

The Times has reported that wide scale adoption of ODM alone could save the NHS substantially over £500m every year.

Contact:

Customer Services 0845 085 0001

email: info@deltexmedical.com

visit: www.reducinglengthofstay.org.uk & www.ftsurgery.com